drugset / Trial / NCT02733588

Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients

NCT02733588

NaSingle-groupOpen-labelTreatment

Summary

The primary objective of this study is to test an optimized control system for sensor-guided (physician administered) delivery of glucagon, and test Proof-of-Concept (POC) in a clinical setting in patients with severe hypoglycemia following bariatric surgery.

Timeline

Start
2016-03
Primary completion
2017-04-05
Completion
2017-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Glucagon Peptide 0.15 mg
Subject Glucagon Peptide 0.3 mg

Indications